Kang Mo Kim Selected Research

Kang Mo Kim Research Topics

Disease

72	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 12/2003
32	Neoplasms (Cancer) 11/2022 - 11/2002
17	Chronic Hepatitis B 03/2022 - 10/2005
14	Fibrosis (Cirrhosis) 12/2021 - 05/2007
9	Liver Diseases (Liver Disease) 01/2015 - 10/2005
8	Liver Neoplasms (Liver Cancer) 01/2019 - 11/2002
6	Cholangiocarcinoma 01/2021 - 03/2009
5	End Stage Liver Disease 12/2021 - 10/2005
4	Hepatitis B 03/2022 - 01/2016
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2012
4	Hepatitis 01/2022 - 06/2007
4	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2009
4	Non-alcoholic Fatty Liver Disease 08/2016 - 05/2010
4	Thrombosis (Thrombus) 03/2015 - 04/2012
3	Disease Progression 04/2021 - 07/2005
3	Infections 01/2016 - 10/2009
2	Hepatic Encephalopathy 01/2020 - 03/2008
2	Inflammation (Inflammations) 05/2018 - 01/2018
2	Fatty Liver 08/2016 - 06/2005
2	Chronic Hepatitis C 06/2014 - 03/2013
2	Hypoxia (Hypoxemia) 01/2012 - 03/2005
1	Varicose Veins (Varicose Vein) 01/2022
1	Atrial Fibrillation 01/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2022
1	Hemorrhage 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Lymphatic Metastasis 09/2020
1	Ascites 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Autoimmune Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

13	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 11/2011
10	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 12/2007
8	Alanine Transaminase (SGPT)IBA 11/2022 - 05/2010
7	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 09/2011
7	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2022 - 06/2005
6	Antiviral Agents (Antivirals)IBA 03/2022 - 07/2005
6	Lamivudine (Epivir)FDA Link 01/2016 - 10/2005
6	entecavir FDA Link 01/2016 - 10/2009
4	Hepatitis B e AntigensIBA 03/2022 - 10/2012
4	Proteins (Proteins, Gene)FDA Link 08/2018 - 02/2011
4	Fetal Proteins (Fetoprotein)IBA 04/2017 - 11/2011
3	NucleosidesIBA 01/2022 - 09/2011
3	Serum AlbuminIBA 10/2021 - 05/2015
3	Pharmaceutical PreparationsIBA 04/2021 - 10/2016
3	gadolinium ethoxybenzyl DTPA FDA Link 01/2019 - 04/2015
3	EnzymesIBA 01/2019 - 03/2005
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 01/2018
3	InterferonsIBA 04/2016 - 06/2007
3	Ethiodized Oil (Ethiodol)FDA Link 06/2013 - 11/2002
3	adefovir dipivoxil (Hepsera)FDA Link 02/2012 - 10/2005
2	Tenofovir (Viread)FDA Link 03/2022 - 01/2022
2	AntigensIBA 03/2022 - 09/2011
2	Iodized OilIBA 02/2022 - 03/2013
2	lenvatinibIBA 04/2021 - 09/2020
2	NivolumabIBA 07/2020 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	Gemcitabine FDA Link 11/2018 - 01/2018
2	CholesterolIBA 01/2018 - 08/2012
2	peginterferon alfa-2a (Pegasys)FDA Link 04/2016 - 03/2013
2	MicroRNAs (MicroRNA)IBA 07/2014 - 05/2014
2	Ribavirin (Virazole)FDA LinkGeneric 06/2014 - 03/2013
2	lipoarabinomannan (LAM)IBA 02/2012 - 06/2006
2	adefovirIBA 10/2009 - 06/2006
2	Bile Acids and Salts (Bile Acids)IBA 08/2006 - 04/2006
1	RNA (Ribonucleic Acid)IBA 11/2022
1	nasIBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	cabozantinibIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Cyclopentanes (Cyclopentane)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	Organophosphonates (Phosphonates)IBA 01/2022
1	L-Iditol 2-Dehydrogenase (L Iditol 2 Dehydrogenase)IBA 12/2021
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 04/2021
1	Arginine (L-Arginine)FDA Link 04/2021
1	Bevacizumab (Avastin)FDA Link 04/2021
1	atezolizumabIBA 04/2021
1	regorafenibIBA 07/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	CytokinesIBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Alkaline PhosphataseIBA 11/2018
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 11/2018
1	Proto-Oncogene Proteins c-rafIBA 08/2018

Therapy/Procedure

27	Therapeutics 04/2021 - 12/2003
11	Radiotherapy 04/2022 - 05/2009
10	Liver Transplantation 01/2020 - 03/2006
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
5	Hepatectomy 01/2020 - 03/2009
3	Immunotherapy 01/2022 - 06/2015
3	Radiofrequency Ablation 12/2015 - 07/2009
2	Salvage Therapy 02/2022 - 10/2013
2	Transplantation 12/2021 - 01/2013
2	Retreatment 10/2016 - 10/2012
2	Surgical Instruments (Clip) 12/2015 - 11/2002
2	Conformal Radiotherapy 01/2015 - 04/2012
1	Combination Drug Therapy (Combination Chemotherapy) 04/2021